BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

YM BioSciences (Formerly York Medical, Inc.) 

5045 Orbitor Drive
Building 11, Suite 400
Mississauga  Ontario  L4W4Y4  Canada
Phone: 905-629-9761 Fax: 905-629-4959


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Discovery





 Company News
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Adds Former YM BioSciences (YM.TO) CEO Nick Glover to Board of Directors 6/11/2013 7:14:08 AM
Gilead Sciences, Inc. (GILD) Completes Acquisition of YM BioSciences (YM.TO) 2/11/2013 8:59:55 AM
YM BioSciences (YM.TO) Reports Operational and Financial Results for the Second Quarter of Fiscal 2013 2/7/2013 8:06:30 AM
YM BioSciences (YM.TO) Announces Receipt of Final Court Order Approving the Plan of Arrangement With Gilead Sciences, Inc. (GILD) 2/5/2013 10:24:38 AM
YM BioSciences (YM.TO) Shareholders Approve Plan of Arrangement With Gilead Sciences, Inc. (GILD) 2/1/2013 9:00:09 AM
YM BioSciences (YM.TO) Plan of Arrangement With Gilead Sciences, Inc. (GILD) Endorsed by Leading Independent Proxy Advisors ISS and Glass Lewis 1/18/2013 9:05:01 AM
YM BioSciences (YM.TO) Announces Record Date for Previously Announced Plan of Arrangement 12/21/2012 11:05:20 AM
Gilead Sciences, Inc. (GILD) Bags Blood Disorder Drug With $510 Million YM BioSciences (YM.TO) Buy 12/12/2012 7:24:18 AM
YM BioSciences (YM.TO) Reports Phase I/II Data for JAK Inhibitor CYT387 in Myelofibrosis at American Society of Hematology 2012 12/10/2012 9:29:39 AM
YM BioSciences (YM.TO) Reports Divestiture of Nimotuzumab Assets by CIMYM 12/4/2012 9:18:35 AM
12345678910...